Cristina giogha
Cristina giogha
Postdoctoral Scientist, Hudson Institute of Medical Research
Verified email at hudson.org.au
Title
Cited by
Cited by
Year
A type III effector antagonizes death receptor signalling during bacterial gut infection
JS Pearson, C Giogha, SY Ong, CL Kennedy, M Kelly, KS Robinson, ...
Nature 501 (7466), 247-251, 2013
2282013
EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation
JS Pearson, C Giogha, S Mühlen, U Nachbur, CLL Pham, Y Zhang, ...
Nature microbiology 2 (4), 1-10, 2017
1062017
EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation
JS Pearson, C Giogha, S Mühlen, U Nachbur, CLL Pham, Y Zhang, ...
Nature microbiology 2 (4), 1-10, 2017
1062017
The Genetics of Enteropathogenic Escherichia coli Virulence
JS Pearson, C Giogha, T Wong Fok Lung, EL Hartland
Annual review of genetics 50, 493-513, 2016
522016
SseK3 is a Salmonella effector that binds TRIM32 and modulates the host’s NF-κB signalling activity
Z Yang, A Soderholm, TWF Lung, C Giogha, MM Hill, NF Brown, ...
PLoS One 10 (9), e0138529, 2015
512015
Inhibition of death receptor signaling by bacterial gut pathogens
C Giogha, TWF Lung, JS Pearson, EL Hartland
Cytokine & growth factor reviews 25 (2), 235-243, 2014
462014
The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD)
NE Scott, C Giogha, GL Pollock, CL Kennedy, AI Webb, NA Williamson, ...
Journal of Biological Chemistry 292 (42), 17337-17350, 2017
372017
Salmonella Effectors SseK1 and SseK3 Target Death Domain Proteins in the TNF and TRAIL Signaling Pathways*[S]
JPM Newson, NE Scott, IYW Chung, TWF Lung, C Giogha, J Gan, ...
Molecular & Cellular Proteomics 18 (6), 1138-1156, 2019
282019
Distinct roles of the antiapoptotic effectors NleB and NleF from enteropathogenic Escherichia coli
GL Pollock, CVL Oates, C Giogha, T Wong Fok Lung, SY Ong, ...
Infection and immunity 85 (4), e01071-16, 2017
252017
The type III effector NleD from enteropathogenic Escherichia coli differentiates between host substrates p38 and JNK
K Creuzburg, C Giogha, T Wong Fok Lung, NE Scott, S Mühlen, ...
Infection and immunity 85 (2), e00620-16, 2017
202017
Substrate recognition by the zinc metalloprotease effector NleC from enteropathogenic Escherichia coli
C Giogha, T Wong Fok Lung, S Mühlen, JS Pearson, EL Hartland
Cellular microbiology 17 (12), 1766-1778, 2015
182015
Mutagenesis and functional analysis of the bacterial arginine glycosyltransferase effector NleB1 from enteropathogenic Escherichia coli
T Wong Fok Lung, C Giogha, K Creuzburg, SY Ong, GL Pollock, Y Zhang, ...
Infection and immunity 84 (5), 1346-1360, 2016
172016
The Salmonella Effector SseK3 Targets Small Rab GTPases
J Gan, NE Scott, JPM Newson, RR Wibawa, T Wong Fok Lung, ...
Frontiers in cellular and infection microbiology 10, 419, 2020
92020
EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation. Nat Microbiol 2: 16258
JS Pearson, C Giogha, S Muhlen, U Nachbur, CL Pham, Y Zhang, ...
62016
Molecular mechanisms employed by enteric bacterial pathogens to antagonise host innate immunity
J Gan, C Giogha, EL Hartland
Current Opinion in Microbiology 59, 58-64, 2021
52021
Filter
RH Scott, K Wellings, L Lindberg
2
NleB2 from enteropathogenic Escherichia coli is a novel arginine-glucose transferase effector
C Giogha, NE Scott, T Wong Fok Lung, GL Pollock, M Harper, ...
PLoS pathogens 17 (6), e1009658, 2021
12021
Sugar fix keeps RIPK3 at bay
C Giogha, KE Lawlor
Immunity 50 (3), 539-541, 2019
12019
Measuring Effector-Mediated Modulation of Inflammatory Responses to Infection with Enteropathogenic and Shiga Toxin-Producing E. coli
GL Pollock, C Giogha, EL Hartland
Shiga Toxin-Producing E. coli: Methods and Protocols, 317-332, 2021
2021
Molecular investigation of enteropathogenic Escherichia coli virulence
C Giogha
2016
The system can't perform the operation now. Try again later.
Articles 1–20